ArticleScience translational medicine2022

The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease.

Miguel Moutinho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.